In an interview for NBC News, Vin Gupta, MD, MPA, MSc, affiliate assistant professor of Health Metrics Sciences at the Institute for Health Metrics and Evaluation (IHME) at…
Dileep R. Yavagal, MD, Professor of Neurology & Neurosurgery and Chief Interventional Neurologist at the University of Miami – Miller School of Medicine, describes a treatment that has…
NEW YORK (Reuters Health) – In young children with acute viral gastroenteritis, rapid nasogastric rehydration (RNR) over four hours in the emergency department is as safe and effective…
NEW YORK (Reuters Health) – The risk of serious falls among elderly patients taking oxybutynin or tolterodine for urinary incontinence is similar, but oxybutynin may increase the risk…
NEW YORK (Reuters Health) – Treating patients with ischemic stroke up to 22 hours after onset with the glycoprotein IIb/IIIa platelet receptor antagonist tirofiban does not increase cerebral…
NEW YORK (Reuters Health) – If patients presenting with chest pain have undetectable levels of troponin when tested using a high-sensitivity assay, they almost certainly do not have…
NEW YORK (Reuters Health) – Vascular access in patients experiencing out-of-hospital cardiac arrest is more reliably and rapidly obtained via needle insertion into the marrow cavity of the…
NEW YORK (Reuters Health) – Aspirin should be tried first in patients with migraine and episodic tension-type headache (ETTH) no matter how bad initial symptoms are, advise the…
NEW YORK (Reuters Health) – The response of adolescents with migraine to treatment with combination sumatriptan and naproxen sodium is similar to that seen in adults, with no…
NEW YORK (Reuters Health) – Treatment of skin and soft-tissue infections (SSTIs) in children in regions where community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) is prevalent is more likely to…
NEW YORK (Reuters Health) – Algorithms based on procalcitonin (PCT) measurements reduce the use of antibiotics without jeopardizing patient safety, according to a review of randomized clinical trials.…
NEW YORK (Reuters Health) – Use of vasopressin provides no overall benefit in the resuscitation of cardiac arrest patients, but it may improve outcomes in a subset of…
